Author:
Jiang Li,Xu Peng,Zhang Dongmei,Lu Jing,Chang Tianying,Zhang Yinbin,Wang Jian
Funder
Jilin Province Philosophy and Social Science Planning Fund Office
Science and Technology Support Program of Jiangsu Province
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference15 articles.
1. Current treatment, emerging translational therapies, and new therapeutic targets for autoimmune myasthenia gravis;Guptill;Neurotherapeutics,2016
2. Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis;Luo;Ann N Y Acad Sci,2018
3. Myasthenia gravis;Gilhus;Nat Rev Dis Primers,2019
4. Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture;Koneczny;Cells,2019
5. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations;Dresser;J Clin Med,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献